US FDA Panel Votes Against Use of Novo Nordisk's Weekly Insulin in Type 1 Diabetes Patients

(Reuters) - A panel of independent experts to the U.S. health regulator on Friday voted against the use of Novo Nordisk's weekly insulin in...

(Reuters) - A panel of independent experts to the U.S. health regulator on Friday voted against the use of Novo Nordisk's weekly insulin in...